Prot #42847922MDD3003: A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with

Project: Research project

Project Details

StatusActive
Effective start/end date3/6/25 → 7/27/27

Funding

  • Janssen Research & Development, LLC (Prot #42847922MDD3003)